72974-120 : Orgovyx 120 mg Oral Tablet, Film Coated


NDC: 72974-120
Labeler: Myovant Sciences, Inc.
Product Type: Human Prescription Drug
Drug Name:  Orgovyx
Dosage Form: Oral Tablet, Film Coated
Application #: NDA214621
Rev. Date: 


NDC Package Codes:

  • 72974-120-01: 30 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC (72974‑120‑01)
  • 72974-120-95: 16 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC (72974‑120‑95)
  • 72974-120-97: 30 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC (72974‑120‑97)

Active Ingredients:

  • Relugolix

Dosage Strength:

  • 120 mg

Pharmaceutical Classes:

  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Cytochrome P450 2B6 Inducers [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Decreased GnRH Secretion [PE]
  • Gonadotropin Releasing Hormone Receptor Antagonist [EPC]
  • Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
  • P-Glycoprotein Inhibitors [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72974-120 QR Code

< Prev: 72973-001Next: 72974-415 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.